0001570562-23-000104.txt : 20230823 0001570562-23-000104.hdr.sgml : 20230823 20230823200707 ACCESSION NUMBER: 0001570562-23-000104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230821 FILED AS OF DATE: 20230823 DATE AS OF CHANGE: 20230823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yamagishi-Dressler Tomoko CENTRAL INDEX KEY: 0001990968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38381 FILM NUMBER: 231198709 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE, SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolus, Inc. CENTRAL INDEX KEY: 0001570562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461385614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: (949) 284-4555 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 4 1 wk-form4_1692835617.xml FORM 4 X0508 4 2023-08-21 0 0001570562 Evolus, Inc. EOLS 0001990968 Yamagishi-Dressler Tomoko 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 0 1 0 0 Chief Marketing Officer 0 Common Stock 2023-08-21 4 A 0 63358 0 A 63358 D Stock Option (Right to Buy) 9.40 2023-08-21 4 A 0 83555 0 A 2033-08-21 Common Stock 83555 83555 D Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of August 21, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of August 21, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. /s/ Jeffrey J. Plumer, as attorney-in-fact for Tomoko Yamagishi-Dressler 2023-08-23